
|Videos|April 26, 2022
ViaLase shares updates on new technology to treat glaucoma, company updates and upcoming trials
Author(s)Kassi Filkins
Tom Frinzi, executive chairman of ViaLase, a new company based in Orange County, gives an update on the company, sharing some exciting new things happening.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
3
Glaucoma innovation: Eight themes to watch in 2026
4
Study shows significant ocular changes following hemodialysis
5












































